Anderson, B.A. et al., "Application of a Practical Biocatalytic Reduction to an Enantioselective Synthesis of the 5H-2,3-Benzodiazepine LY300164," J. Am. Chem. Soc. 117:12358-12359 (Dec. 1995). |
Buchan, A.M. et al., "AMPA Antagonists: Do They Hold More Promise for Clinical Stroke Trials Than NMDA Antagonists?" Stroke 24(Suppl. I):I-148-I-152 (1993). |
De Sarro, G. et al., "GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice," Eur. J. Phamacol. 294:411-422 (Dec. 1995). |
Gatta, F. et al., "Derivatives of 2,3-Benzodiazepine," IL Farmaco-Ed. Sc. 40:942-955 (1985). |
Keana, J.F.W. et al., "Synthesis and Structure-Activity Relationships of Substituted 1,4-Dihydroquinoxaline-2,3-diones: Antagonists of N-Methyl-D-aspartate (NMDA) Receptor Glycine Sites and Non-NMDA Glutamate Receptors," J. Med. Chem. 38:4367-4379 (Oct. 1995). |
Larson, J. et al., "Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats," Brain Res. 738:353-356 (Nov. 1996). |
Sheardown, M.J. et al., "AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h," Eur. J. Pharm. 236:347-353 (1993). |
Staubli, U. et al., "Facilitation of glutamate receptors enhances memory," Proc. Natl. Acad. Sci. USA 91:777-781 (1994). |
Thomas, R.J., "Excitatory Amino Acids in Health and Disease," JAGS 43:1279-1289 (Nov. 1995). |
Bennett, M.V.L. et al., "The GluR2 Hypothesis: Ca.sup.++ -permeable AMPA Receptors in Delayed Neurodegeneration," Cold Spring Harbor Symposia on Quantitative Biology LXI:373-384 (Jun. 1996). |
Blin, O., "Should N-Methyl-D-Aspartate or Non-N-Methyl-D-Aspartate Glutamate Receptor Antagonists Be Used in Amyotrophic Lateral Sclerosis?," in: Pathogenesis and Therapy of Amyotrophic Lateral Sclerosis, Serratrice, G. and T. Musat, eds., Lippincott-Raven Publishers, Philadelphia, PA, pp. 259-261 (1995). |
Graham, S.H. et al., "A Dose-Response Study of Neuroprotection Using the AMPA Antagonist NBQX in Rat Focal Cerebral Ischemia," J. Pharmacology & Exper. Therapeutics 276:1-4 (Jan. 1996). |
Hunter, J.C. and L. Singh, "Role of excitatory amino acid receptors in the mediation of the nociceptive response to formalin in the rat," Neurosci. Letters 174:217-221 (1994). |
Johnson, S.A. et al., "Antagonism of Methamphetamine-Induced Hyperactivity in Rats by Specific Facilitation of AMPA-Receptor-Mediated Glutamatergic Transmission," Soc. Neurosci. 22:1676, Abstract No. 657.12 (1996). |
Karcz-Kubicha, M. and S. Liljequist, "Evidence for an anxiogenic action of AMPA receptor antagonists in the plus-maze test," Eur. J. Pharmacol. 279:171-177 (Jun. 1995). |
Lynch, G. et al., "Evidence That a Positive Modulator of AMPA-Type Glutamate Receptors Improves Delayed Recall in Aged Humans," Exper. Neurol.145:89-92 (May 1997). |
Palmer, L.C. et al., "Evidence That Positive Modulators of AMPA Receptors Increase Aggregate Neuronal Activity in Neocortex Relative to Striatum: Relevance to Schizophrenia," IBC's Second Intl. Symposium on Schizophrenia: Latest Advances in Understanding and Drug Development, Philadelphia, PA (Jun. 1996). |
Schuller, J.J. and J.F. Marshall, "Intrastriatal DNQX induces rotation and pallidal Fos in the 6-OHDA model of Parkinson's disease," NeuroReport 6:2594-2598 (Dec. 1995). |
Yamakura, T. et al., "The sensitivity of AMPA-selective glutamate receptor channels to pentobarbital is determined by a single amino acid residue of the .alpha.2 subunit," FEBS Letters 374:412-414 (Nov. 1995). |
Yoshiyama, M. et al., "Effects of GYKI 52466 and CNQX, AMPA/kainate receptor antagonists, on the micturition reflex in the rat," Brain Res. 691:185-194 (Sep. 1995). |
Gatta et al., Chromium Trioxide Oxidation Products From 4-Spiro-1-Phenylisochromans, Journal of Heteocyclic Chemistry, vol. 20, No. 5, pp. 1267-1270, Sep. 1983. |
Tomori et al., Pharmacokinetic and Metabolism Studies on Girisopam by Chromatographic and Spectrometric Methods in Humans, Journal of Chromatography, vol. 578, pp. 91-101, 1992. |
Pelaggi et al., Electronic and Conformational Properties of 2,3-Benzodiazepine Derivatives, STN Printout, 1996. |
Flammang, 2,3-Benzodiazepines: 2-Amino-3-Isoquinolinones From Ring Contraction of 4-oxo-2,3-Benzodiazepines, STN Printout, 1980. |
Flammang et al., 2,3-Benzodiazepine Systems, STN Printout, 1976. |
Nagarajan et al., Derivatives of 3,5-dihydro-4H-benzo�2,3!diazepin-4-one, STN Printout, 1972. |
Beal, Aging, Energy, and Oxidative Stress in Neurodegenerative Diseases, Ann. Neurol., vol. 38, pp. 357-366, 1995. |